News

The approval allows treatment-experienced adults living with HIV who are virally suppressed to switch to doravirine or doravirine/lamivudine/tenofovir disoproxil fumarate.

Along with other heart ailments, new research finds that people living with HIV have a greater risk of atrial fibrillation.

Through June 2019, there were 725 confirmed cases of C auris in the New York City, New Jersey and Chicago regions, with 30 additional probable cases documented.

The SLATE study evaluated whether a clinical algorithm can help clinicians determine eligibility for same-day treatment among people living with HIV and initiate ART when appropriate.

In this outbreak, 18% of Ebola cases have been tied to health care transmission. How can we prevent this from continuing?

The vaccination schedule in Kenya will consist of 4 doses of the RTS,S vaccine: 3 doses given between 6 and 9 months of age and the fourth dose given at 24 months.

Can UV disinfecting lights tackle health care-associated infections?

Touring production called “Eureka Day” depicts parents of schoolchildren arguing both sides—but definitely has a point of view.

People are living long lives with HIV care, but it is important to acknowledge aging-related challenges of HIV prevention, testing, treatment, and care.

According to the CDC, there were no new cases of measles reported during the week of September 6-12, 2019.

A nationwide cohort study in Denmark examined hypertensive populations and the protective effects awarded by the influenza vaccination.

A recent study found evidence of herd immunity to HPV oral infection among unvaccinated men aged 18 to 59 years in the United States.

The target action date for the V920 investigational Ebola vaccine is set for March 14, 2020.

Infection with pertussis or influenza can be serious, and in some cases deadly, in newborn babies, therefore it is critical for pregnant women to receive the Tdap and influenza vaccines.

A NIAID-sponsored study found that most participants who received a 5-day course of broad-spectrum antibiotics prior to a season flu shot had reduced levels of gut bacteria.

Between July and August 2016, a decrease of 10.4 days of therapy per 1000 patient days (7.6%; P = .002) was observed.

A new study delves into the debate of N95 respirators versus surgical masks for seasonal influenza and other respiratory illnesses.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of September 8, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A total of 130 influenza-associated pediatric deaths were reported during the 2018-19 flu season.

The prevalence of sexually transmitted infections is rising, and a new study suggests a higher risk for HIV-positive MSM whose partners use PrEP.

Although drinking water-associated outbreaks are rarely reported in the United States, they were the most commonly reported etiology for outbreaks associated with untreated ground water from 1971-2008.

A study conducted in Kenya demonstrated that appealing to women who present at family-planning clinics to obtain birth control can increase the percentage who will use PrEP.

Even though leprosy is not widespread in the United States, the current landscape in some cities, such as Los Angeles, is creating the perfect environment for so-called “ancient” diseases to flourish.

Study investigators assessed the nationwide incidence of sepsis within 42 days of delivery discharge.

Following outbreaks and disinfecting failures, new recommendations advocate for duodenoscopes with disposable components seek to drive change in reducing risk of patient infections.

A novel combination of ceftriaxone, sulbactam and disodium EDTA (CSE) was found noninferior to meropenem to treat cUTIs caused by gram-negative pathogens.

In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services from both the clinician and industry perspective.

Japanese researchers work to refine RDV, a tool for rapid identification of pathogenic agents.